A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

July 6, 2023

Study Completion Date

July 6, 2023

Conditions

Atherosclerotic Cardiovascular DiseaseHypercholesterolemia

Trial Locations (1)

Novartis, East Hanover